Alpine Immune Sciences, Inc.
CD112 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

Last updated:

Abstract:

Provided herein are immunomodulatory proteins comprising variant CD112 and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.

Status:
Application
Type:

Utility

Filling date:

27 Jul 2017

Issue date:

19 Aug 2021